Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Coconut oil’s role in Alzheimer’s and depression

Marc Arginteanu, MD
Conditions
September 15, 2025
Share
Tweet
Share

There is evidence that coconut oil may be a potent weapon in the battle against Alzheimer’s disease and other types of dementia and, perhaps, psychological problems such as depression.

Not just any coconut oil will do the trick, though. Virgin coconut oil (VCO) is extracted from fresh coconut meat without the use of high heat or chemicals, preserving its natural nutrients, flavor, and aroma. VCO is typically pressed from fresh, moist coconut flesh, a process called “wet-milling,” or by cold-pressing dried coconut meat (copra). VCO is solid at room temperature, but melts in your mouth above seventy-six degrees Fahrenheit.

Refined coconut oil, on the other hand, has been through processing that often leaves it deodorized, bleached, or otherwise altered, diminishing its appeal.

Alzheimer’s disease

Several studies have explored the potential of coconut oil to improve brain function in Alzheimer’s disease and other cognitive impairments.

In 2019, Canadian researchers evaluated more than eighty volunteers to determine whether a coconut oil-based drink could improve cognitive function. Half of the participants received the special formula, while the others consumed a placebo for more than six months. Those who drank the coconut oil beverage experienced significantly improved memory and language function, as reported in this study.

In 2024, Saudi Arabian scientists reviewed medical literature and concluded that the bioactive ingredients in coconut oil may improve memory in those with Alzheimer’s disease and significantly slow disease progression, according to their analysis.

Coconut oil is rich in medium chain triglycerides (MCTs), which are linked to improved metabolism and antimicrobial properties. Up to sixty-five percent of coconut oil is comprised of MCTs—primarily lauric acid, caprylic acid, and capric acid. MCTs are rapidly converted to ketones in the liver, providing the brain with an alternative energy source when glucose metabolism is impaired, as in Alzheimer’s disease. Ketones from MCTs may bypass glucose deficits, reduce oxidative stress, decrease amyloid-beta plaque formation, increase cerebral blood flow, and support mitochondrial function.

The beneficial effects of MCTs on Alzheimer’s disease are most pronounced in those with two copies of the APOE4 gene.

Apolipoprotein E is a protein that helps transport cholesterol and fats in the bloodstream and brain. The APOE gene has three common variants: APOE2, APOE3, and APOE4. The APOE4 variant is associated with an increased risk of Alzheimer’s disease and cardiovascular issues.

Depression

In 2023, Chinese researchers conducted an animal study suggesting that virgin coconut oil may have antidepressant-like effects. Rats were induced to exhibit depressive behavior through elevated blood levels of lipopolysaccharides (LPS), then treated with VCO. The treatment significantly alleviated depression-like behaviors and reduced neuroinflammation, while improving mitochondrial function in the hippocampus and prefrontal cortex, as described in this study.

In 2024, Iranian researchers randomized sixty volunteers to receive either VCO or a placebo for eight weeks and found that the VCO group experienced a significant increase in brain-derived neurotrophic factor (BDNF), as reported in this trial.

BDNF is a protein that supports the function of the hippocampus and basal forebrain, encouraging the growth and differentiation of new neurons and synapses. It also enhances the survival of neurons in degenerative diseases. In Parkinson’s disease, for example, BDNF supports dopaminergic neurons, improves neurotransmission, and enhances motor performance. Low levels of BDNF are well established in depression.

Other options

ADVERTISEMENT

Numerous studies have suggested benefits of purified MCTs in Alzheimer’s disease. In 2019, Japanese researchers gave patients with Alzheimer’s disease a ketogenic formula based on MCTs. Participants showed significant improvements in memory and executive function, as measured by the Alzheimer’s Disease Assessment Scale-Cognitive Subscale.

Purified MCT oils are used in specially engineered ketogenic formulas, which are more concentrated and produce higher ketone levels than coconut oil. One well-known formulation is Axona, a medical food containing caprylic acid, marketed for Alzheimer’s disease.

Before adding coconut oil to your diet, keep in mind that its high saturated fat content—eighty to ninety percent, primarily lauric acid—may increase LDL cholesterol, posing cardiovascular risks.

Marc Arginteanu is a neurosurgeon and author of Azazel’s Public House.

Prev

How policy and stigma block addiction treatment

September 15, 2025 Kevin 0
…
Next

A doctor's guide to preparing for your death

September 15, 2025 Kevin 0
…

Tagged as: Neurology

Post navigation

< Previous Post
How policy and stigma block addiction treatment
Next Post >
A doctor's guide to preparing for your death

ADVERTISEMENT

More by Marc Arginteanu, MD

  • How gut bacteria shape your mental health and mood

    Marc Arginteanu, MD
  • How the shingles vaccine could help prevent dementia

    Marc Arginteanu, MD
  • Diabetes and Alzheimer’s: What your blood sugar might be doing to your brain

    Marc Arginteanu, MD

Related Posts

  • The expanding role of specialists in value-based care

    Martin Lustick, MD
  • The role of income in medical school acceptance

    Carter Do
  • Surviving medical school with depression

    Anonymous
  • The role of residents in teaching and creating a positive clinical learning environment

    Reem Al Shabeeb
  • AI’s role in streamlining colorectal cancer screening [PODCAST]

    The Podcast by KevinMD
  • The physician’s crucial role in combating climate change

    Megan McLaughlin

More in Conditions

  • Why senior-friendly health materials are essential for access

    Gerald Kuo
  • Why smoking is the top cause of bladder cancer

    Martina Ambardjieva, MD, PhD
  • How regulations restrict long-term care workers in Taiwan

    Gerald Kuo
  • The obesity care gap for U.S. women

    Eliza Chin, MD, MPH, Kathryn Schubert, MPP, Millicent Gorham, PhD, MBA, Elizabeth Battaglino, RN-C, and Ramsey Alwin
  • What heals is the mercy of being heard

    Michele Luckenbaugh
  • Why police need Parkinson’s disease training

    George Ackerman, PhD, JD, MBA
  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...